Clinical Trials
6 trialsNCT02821754 2023-03-28
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03183219 2020-07-13
Safety and Efficiency of γδ T Cell Against Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT01853618 2019-12-10
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02843802 2019-09-12
Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02545556 2016-08-29
Liver Cancer HepaSphere Combined With Cryosurgery
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT00002655 2013-07-22
Cryosurgery in Treating Patients With Liver Cancer or Liver Metastases
University of Colorado, Denver
Phase 2 Completed